PDS Biotechnology Corporation
PDSB · NASDAQ
Bulios Fair Price
$0.41
45.2% downside
Trenutna cena
$0.75
Po podatkih Bulios Fair Price je delnica PDSB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
PDS Biotechnology Corporation is a biotechnology company focused on developing immunotherapeutic drugs for the treatment of various types of cancer and infectious diseases. Their main product is a platform called Versamune™, which combines antigen presentation with immune response activation, allowing for the creation of effective vaccines and immunotherapies. This platform is designed to activate and bolster the patient's immune system to fight against cancer and infections. PDS Biotechnology Corporation aims to develop innovative therapeutic approaches that can improve the treatment of these serious diseases and contribute to better patient health.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Frank K. Bedu-Addo
Employees
21
Headquarters
Princeton
Prihajajoči dogodki
Earnings
Upcoming earnings report